DPZ — Domino's Pizza, Inc.
Domino's Pizza, Inc. operates as a leading international and domestic purveyor of pizza, managing its extensive operations through three distinct segments: U.S. Stores, International Franchise, and Supply Chain.
Price chart & technical analysis
Loading chart…
As of 2026-10-13, Domino's Pizza trades at $297.32 (down 4.4% on the day, roughly -25% year-to-date and -22.5% over six months), sitting only ~5% above its 52-week low of $282. The same-day Q3 2026 filing beat on revenue ($1.186B, +3.4% YoY) and EPS ($4.60 vs ~$4.38 expected), but domestic same-store sales grew just 0.3%.
The market is bearish because the beats are arithmetic, not organic: U.S. same-store sales of +0.3% (company-owned +1.0%, franchise +0.3%) confirm that traffic in the core domestic business has plateaued, and investors will not pay a premium multiple for a flat largest market. The stock is down ~25% YTD through late 2026 and shed another 2-3% premarket on the Q3 release, and the tape confirms sustained distribution - as of 2026-10-13 DPZ sat 4.17% below its 20-day, 11.79% below its 50-day and 18.08% below its 200-day SMA. Sell-side is more constructive (26 Buy / 25 Hold / 1 Sell, consensus target $372.19), but price action shows the market is trading the same-store-sales line, not the EPS beat.
Revenue growth is decelerating from a high base rather than collapsing: YoY growth ran +6.4% in Q4 2025 and +6.2% in Q3 2025, then slowed to +3.5% (Q1 2026), +4.3% (Q2 2026) and +3.4% in Q3 2026 ($1.186B vs $1.147B). Profitability is moving the other way - operating margin climbed from 18.4% in Q3 2024 to 19.5% (Q3 2025), 20.0% (Q1 2026) and 20.4% in Q3 2026, a roughly 200bp two-year expansion management attributes to supply-chain gross margin (12.2% vs 11.3%). EPS is lumpy on tax/comps - Q1 2026 fell 4.6% YoY to $4.13 against a $4.33 comp - but the last three prints are positive: $5.35 (+9.4%), $4.07 (+6.8%) and $4.60 (+12.7%). Free cash flow is remarkably stable at $146.9M-$175.9M every quarter for eight straight quarters with no deterioration. Read this as a mature compounder with expanding margins and a slow top line - a domestic demand trough, not a structural earnings decline - with one caveat: the quarter ended 2026-09-06 shows a ~$1.9B swing in total liabilities and stockholders' equity versus 2026-06-14 that nothing in the research brief explains.
Cheap on absolute and relative measures, only fair on growth-adjusted measures. As of 2026-10-13 DPZ traded at 16.37x TTM EPS of $18.446 and ~15.6x next-FY consensus EPS of $19.005, versus a 5-year average P/E of 28.87x - roughly a 45% discount to its own history. P/S of 1.945x compares to a 5-year average of 3.34x. Dividend yield is 2.48% and TTM FCF of ~$653M equals a 6.6% FCF yield on the $9.84B market cap. The catch: PEG is 2.876, meaning the P/E is only 'cheap' if growth re-accelerates - at a ~5-6% EPS growth rate the multiple is fair, not distressed. Verdict: moderately cheap, contingent on U.S. same-store sales inflecting off +0.3%.
The stock is priced for the current run-rate to persist, not for a recovery: at ~15.6x forward EPS the market ascribes essentially zero value to a U.S. comp inflection, which is why a clean beat quarter (revenue $1.186B vs ~$1.17B consensus, EPS $4.60 vs ~$4.38) produced only a 2-3% premarket dip and no re-rating. That cuts both ways. Upside: if U.S. SSS normalizes to 2-3% while international keeps adding ~150 net units a quarter (175 net global openings in Q3 2026), EPS compounds at high single digits and the multiple has room back to the low-20s - that alone is $400+. Downside: if U.S. SSS stays at 0-1%, consensus FY EPS of $19.005 is exposed and 15.6x can compress to 13x. The asymmetry favors patience, but only for investors willing to underwrite a turnaround the comps haven't shown yet.
Clear downtrend, no bottom yet. As of 2026-10-13, RSI(14) was 34.81 - weak but not the sub-30 reading that has marked durable lows in this name - with price 4.17% below the 20-day, 11.79% below the 50-day and 18.08% below the 200-day SMA, and returns of -5.5% (1 week), -8.2% (1 month), -7.7% (3 months) and -22.5% (6 months). At $297.32 the stock is only ~5% above the 52-week low of $282, so the next support test is imminent. Entry-timing implication: this is a falling knife; I would want either a sub-30 RSI washout with a reversal day or a reclaim of the 20-day SMA before treating any level here as a low.
- Consumer value sensitivity: QSR traffic is under pressure as lower- and middle-income consumers cut discretionary dining; Domino's is answering with heavy discounting (e.g., National Pizza Month 50%-off menu-priced pizzas), which defends traffic but caps ticket growth and squeezes franchisee margins.
- Input cost tailwind: food basket inflation has moderated to +2.2% YoY, directly supporting the supply-chain gross margin recovery (12.2% in Q3 2026 vs 11.3% prior year) that is currently the main driver of operating margin expansion.
- Labor and wage inflation: franchise-level operating margins remain squeezed by wage costs, which is ultimately a franchisee-profitability issue that caps royalty growth and new-unit economics.
- Rates and refinancing: DPZ carries a large securitized debt load against negative book equity; elevated financing costs make both upcoming debt maturities and the pace of its multi-billion-dollar buyback authorization live swing factors for per-share earnings.
- International and FX exposure: 149 of the 175 net Q3 2026 unit openings were international (~85%), so emerging-market consumer conditions and currency translation increasingly drive consolidated global retail sales growth (+3.2% in Q3 2026).
- New CEO Joe Jordan, who formally took over on 2026-10-01, rolling out a strategy focused on franchisee profitability and digital/AI ordering (DomOS platform, AI-powered tracking) - a credible re-rating catalyst if paired with a credible U.S. traffic plan.
- Any inflection in U.S. same-store sales off the +0.3% Q3 2026 print; even a move to 2% would likely reset a multiple that sits at 15.6x forward EPS versus a 28.87x 5-year average.
- Debt refinancing and capital allocation updates, including the pacing of share repurchases against elevated financing costs.
- Continued international unit growth (149 net openings in Q3 2026) compounding high-incremental-margin royalty revenue.
- Next earnings report on 2027-02-22 (estimated), which will frame the FY2027 outlook under new leadership.
- U.S. same-store sales staying stuck at ~0-1%, which would expose consensus FY EPS of $19.005 and make the 15.6x forward P/E look fair rather than cheap (PEG is already 2.876).
- Balance-sheet opacity: stockholders' equity of -$2.08B, a current ratio of 0.488, and an unexplained ~$1.9B swing in total liabilities between 2026-06-14 ($5.75B) and 2026-09-06 ($3.84B) alongside long-term debt falling from $4.876B to $0.190B - the research brief does not address this, and debt/equity ratios were excluded from the deterministic score as distorted.
- Leverage and refinancing risk: a large securitized debt stack against negative book equity, with high financing costs constraining both buybacks and dividend growth.
- Competitive intensity and discounting in U.S. pizza (Little Caesars, Papa John's, fast-casual), which keeps the value wars going even as food costs moderate.
- Execution risk under an untested new CEO, plus wage inflation squeezing franchisee-level margins and therefore new-unit demand.
DPZ is a genuinely high-quality franchise machine - 56.7% ROIC, ~20.4% Q3 2026 operating margin, ~$653M TTM free cash flow (6.6% FCF yield) and a 2.48% dividend - trading at ~15.6x forward EPS against a 5-year average of 28.87x, but the discount isn't free money. U.S. same-store sales are frozen at +0.3%, the deterministic score lands at 39.4 ('Weak Fundamentals') largely on negative equity and sub-1.0 liquidity ratios that are structural to the franchise/securitization model rather than distress signals, and the latest quarter carries a ~$1.9B unexplained balance-sheet shift. This is a value-with-a-catalyst stock, not a clean buy: I would want either a U.S. comp inflection or management clarity on the balance sheet before underwriting the recovery, and the tape (RSI 34.8, 18% below the 200-day) says the market agrees.
I blended three independent approaches as of 2026-10-13: (1) 19x forward FY EPS of $19.005 = $361; (2) a 5.5% required free-cash-flow yield on TTM FCF of ~$653M = ~$11.88B equity value, or ~$359 on 33.08M shares; and (3) 14.5x EV/EBITDA on ~$1.10B TTM EBITDA less ~$4.5B net debt = ~$346. All three converge, so I use the ~$355 blend - a below-consensus multiple (19x vs the 28.87x 5-year average) because U.S. same-store sales are still +0.3% and the balance sheet has unexplained items, but a clear premium to the current 15.6x forward because a 6.6% FCF yield and 56.7% ROIC do not justify a mid-teens multiple on a franchise compounder.
I'd rate the score higher than 39.4 - roughly 52-55, i.e. 'Fair Fundamentals' rather than 'Weak' - for three reasons the formula structurally cannot see. First, the ratio screener (29.3) and financial-health leg (33.2) are dominated by metrics that are artifacts of the business model: negative stockholders' equity is the residue of decades of buybacks and securitized debt, not distress, and a 0.488 current ratio is normal for a franchisor that collects royalties and passes supply-chain costs through - penalizing DPZ for this is like penalizing a bank for a low current ratio. Second, the -3.11% accruals ratio (cash flow exceeding reported net income) is a genuine earnings-quality positive, and 56.7% ROIC with ~200bp of two-year operating margin expansion is not a 'weak fundamentals' profile. Third, the U.S. same-store sales slowdown to +0.3% looks cyclical/competitive rather than structural, given continued global unit growth (175 net openings in Q3 2026) and global retail sales +3.2% - exactly the trough-vs-decline distinction a purely backward-looking score cannot make. Offsetting this, I would not go all the way to 'Good': the unexplained ~$1.9B swing in liabilities/equity in the quarter ended 2026-09-06 genuinely reduces visibility, and leverage constrains how much of the buyback can compound per-share results. Net: the band is one tier too harsh, so Partially Agree; the Cautiously Bearish lean that follows from the given band plus 'Cheap vs. its own history' label is directionally fair, since this stock is cheap for identifiable reasons.
AI-generated analysis for informational purposes only, not financial advice.